XOMA Royalty (XOMA) EBT Margin (2011 - 2026)
XOMA Royalty (XOMA) reported EBT Margin of 36.26% for Q1 2026, down 2292.0% on a YoY basis from 1.65% in Q1 2025, and down 45.73% sequentially from 66.81% in Q4 2025.
XOMA Royalty (XOMA) EBT Margin (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of EBT Margin data on file, last reported at 36.26% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 2292.0% year-over-year to 36.26%; the trailing twelve-month figure through Mar 2026 stood at 13.99% (up 32193.0% YoY), and the FY2025 full-year result was 61.01%, up 35290.0% from the prior year.
- EBT Margin eased to 36.26% in Q1 2026, from 66.81% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 66.81% in Q4 2025 to a low of 5593.78% in Q3 2023.
- A 5-year average of 1390.03% and a median of 730.17% in 2024 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin tumbled 1570959 bps in 2022 and surged 535419 bps in 2024, its largest moves.
- Tracing XOMA's EBT Margin over 5 years: stood at 736.59% in 2022, then slumped by 112 bps to 1565.23% in 2023, then slipped by 22 bps to 1911.6% in 2024, then soared by 103 bps to 66.81% in 2025, then slumped by 46 bps to 36.26% in 2026.
- Business Quant data shows XOMA's EBT Margin at 36.26% in Q1 2026, 66.81% in Q4 2025, and 221.13% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 36.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.26% |
| Dec 31, 2025 | 66.81% |
| Jun 30, 2025 | -221.13% |
| Mar 31, 2025 | 59.18% |
| Dec 31, 2024 | -1,911.60% |
| Sep 30, 2024 | -239.59% |
| Jun 30, 2024 | -538.49% |
| Mar 31, 2024 | -723.76% |
| Dec 31, 2023 | -1,565.23% |
| Sep 30, 2023 | -5,593.78% |
| Jun 30, 2023 | -1,048.67% |
| Mar 31, 2023 | -2,532.49% |
| Dec 31, 2022 | -736.59% |
| Sep 30, 2022 | -3,249.67% |
| Jun 30, 2022 | -3,964.76% |
| Mar 31, 2022 | -76.91% |
| Dec 31, 2021 | 14,973.00% |
| Sep 30, 2021 | -806.55% |
| Jun 30, 2021 | -248.28% |
| Mar 31, 2021 | -1,966.13% |